Print
Clinical Quality Indicators
Clinical Quality Indicators are specifications adapted from the National Committee for Quality Assurance (NCQA). The methodology used for reporting the Clinical Quality Indicators includes all specialty-appropriate practitioners involved in the care of a member during the relevant time frame as that member’s “team.”
The specific criteria for defining which practitioners to include in the team vary by indicator. All of the Clinical Quality Indicators have been structured so that higher rates represent better performance.
PPO and BlueChoice Select Clinical Quality Indicator Abstracts
- Annual Monitoring for Patients on Persistent Medications: Members on Anticonvulsants
- Annual Monitoring for Patients on Persistent Medications: Members on Digoxin
- Annual Monitoring for Patients on Persistent Medications: Members on Diuretics
- Annual Monitoring for Patients on Persistent Medications: Members on ACE/ARBs
- Appropriate Testing for Children with Pharyngitis
- Appropriate Treatment for Children with Upper Respiratory Infection (URI)
- Asthma Medication Management
- Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis
- Breast Cancer Screening
- Cervical Cancer Screening
- Childhood Immunization Status: MMR/VZV
- Chlamydia Screening for Women
- Cholesterol Management for Patients with Cardiovascular Conditions
- Colorectal Cancer Screening
- Comprehensive Diabetes Care
- E&M Codes Used for Attribution Purposes
- PPO Practitioner Profile User Guide
